Make WallSt.net My Homepage! Become a Member - FREE!  
Username:    Password:  
News & Commentary Tools & Research  Community  Video / Audio Blogs & Boards Shop
Featured Show
This video was published 627 Days 34 Mins ago.

Member Access: Available NOW
Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.

The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.

Members are encouraged to ask these executives questions through their message boards at Mywallst

3 Minute Press Show - Wednesday, July 2, 2008
Loading..
Featured Company:
Alseres Pharmaceuticals, Inc.

Exchange:
NASDAQ

Ticker:
ALSE

Interviewee:
Peter Savas
Chairman & CEO



Back to Full Show
Alseres Pharmaceuticals, Inc. (ALSE)

Alseres Pharmaceuticals, Inc. is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's energy and focus is reflected in several important initiatives. Cethrin, a recombinant-protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including bone repair. The Company has a robust molecular imaging development program targeting diagnosis of Parkinson's disease and potentially dementia. The Company's lead molecular imaging product candidate is Altropane which is in Phase III clinical trials for the diagnosis of Parkinsonian Syndromes including Parkinson's Disease. The Company has research collaborations with Harvard Medical School and Children's Hospital Boston.




  User Comments

0
Bulls
   0
Bears
     






Be the first to comment on
Alseres Pharmaceuticals, Inc. (NASDAQ: ALSE)





Comment on Alseres Pharmaceuticals, Inc.
Please log in to post a comment.
Username:    Password:  

Don't have an account? 

Members Following This Stock
AlbertAimers


WallStNick
paramaxrd

Featured Companies
General Electric Co.

Stephen Ulanoski
General Manager, GE Capital Fleet Services Telematics Program
Friday, January 9, 2009

General Electric Company (GE) operates as a technology, media, and financial services company worldwide. It operates through four segments: GE Capital, Energy Infrastructure, Technology Infrastructure…

Domino's Pizza, Inc.

Russell Weiner
Chief Marketing Officer
Thursday, January 8, 2009

Founded in 1960, Domino's Pizza is the recognized world leader in pizza delivery. Through its primarily locally-owned and operated franchised system, Domino's operates a network of 8,726 franchised and…

Starwood Hotel & Resorts Inc.

Ray Hammer
GM of Sheraton Dallas Hotel
Friday, December 19, 2008

Starwood Hotels & Resorts Worldwide, Inc., together with its subsidiaries, operates as a hotel and leisure company worldwide. It primarily operates luxury and upscale full service hotels, retreats, and…



Latest Episodes
3 Minute Press Show  - 07.23.09

Black Dragon Resource Inc.
3 Minute Press Show  - 07.20.09
GTX Corp.
3 Minute Press Show  - 07.09.09

Flame Seal Products, Axcess International Inc., Micro Imaging Technology, TurboSonic Inc., American Resource Technologies Inc.
3 Minute Press Show  - 07.07.09

Uni-Pixel Inc., SNM Global Holdings, Octus Inc., Pluristem Therapeutics Inc., Trade Wind Ventures Inc., NavStar Technologies Inc.
3 Minute Press Show  - 07.02.09
Juma Technology Corp., American Security Resources Corp., HearAtLast Holdings, International Stem Cell Corp.,


HOME | VIDEO INDEX | SUPPORT | EDITORIAL | CONFLICT POLICY | TERMS OF USE | CONDITIONS OF USE | PRIVACY POLICY | DISCLAIMER | SERVICES | CONTACT US

©2010 Wallstreet Direct Inc., a Financial Media Group Inc. Company (Ticker Symbol: FNGP). All Rights Reserved.
The views and ideas expressed in the podcasts on this site do not necessarily reflect those of WallSt Radio or its affiliates.